tiprankstipranks
Trending News
More News >
Cellularline SpA (IT:CELL)
:CELL
Italy Market

Cellularline SpA (CELL) AI Stock Analysis

Compare
0 Followers

Top Page

IT:CELL

Cellularline SpA

(CELL)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 5.2)
Rating:65Neutral
Price Target:
€3.00
▲(8.70% Upside)
The score is driven mainly by improving fundamentals—returned profitability, moderate leverage, and consistently positive free cash flow—while the largest constraint is cooling growth (TTM revenue decline) alongside only modest margins/returns. Technicals are mixed and not strongly supportive, but valuation is favorable with a low P/E and a healthy dividend yield.
Positive Factors
Returned profitability and steady gross margins
Cellularline has re-established profitability after 2022 losses and maintained gross margins near the high-30% to ~40% range. This stability in core product economics supports sustainable operating leverage and predictable unit-level margins across device cycles over the next several quarters.
Manageable leverage and solid equity base
Net debt around 0.3x equity signals a conservative capital structure that preserves financial flexibility. With equity sizable relative to assets, the company can fund product investment, absorb demand volatility, and pursue opportunistic distribution or product initiatives without destabilizing liquidity.
Consistent positive free cash flow and cash conversion
Consistently positive operating and free cash flow, with FCF ~75% of net income, indicates high cash conversion and internal funding capacity. This underpins dividend support, reinvestment into product development, and a buffer against cyclical demand downturns over the medium term.
Negative Factors
Cooling revenue / TTM revenue decline
Trailing-twelve-month revenue contraction reflects weakening top-line momentum. In a low-margin accessories market, sustained revenue declines can quickly pressure operating leverage, reduce scale benefits in retail/distribution, and limit ability to invest in innovation or marketing.
Modest returns and limited profitability cushion
ROE near 4% and mid-single-digit net margins imply limited profitability headroom. Modest returns reduce resilience to competitive pricing, input cost rises, or channel shifts, constraining capital allocation and potential to generate meaningful shareholder returns absent stronger revenue growth.
Operating cash flow is a small share of revenue
OCF representing mid-teens of revenue means cash generation is sensitive to margin compression or working-capital swings. In the accessories business, inventory or receivables volatility could rapidly erode cash flow, limiting flexibility for capex, buybacks, or cushioning cyclical downturns.

Cellularline SpA (CELL) vs. iShares MSCI Italy ETF (EWI)

Cellularline SpA Business Overview & Revenue Model

Company DescriptionCellularline SpA (CELL) is an Italian company specializing in the design and manufacture of accessories for mobile devices, including smartphones, tablets, and wearables. The company operates primarily in the consumer electronics sector and offers a wide range of products such as protective cases, chargers, audio accessories, and screen protectors. Cellularline is known for its innovative solutions that enhance the user experience and provide functionality and style to mobile technology.
How the Company Makes MoneyCellularline generates revenue through the sale of its diverse range of mobile accessories and products. The company's primary revenue streams include direct sales to consumers through retail channels, e-commerce platforms, and partnerships with mobile operators and electronics retailers. Additionally, Cellularline benefits from strong brand recognition and customer loyalty, which drive repeat purchases. Strategic partnerships with manufacturers and distributors also contribute to its earnings, allowing the company to expand its market reach and increase product availability. Seasonal promotions and new product launches further enhance sales potential.

Cellularline SpA Financial Statement Overview

Summary
Post-2022 recovery is evident with profits positive again, steady gross margins, manageable leverage (~0.30x equity), and consistently positive operating/free cash flow. Offsetting this, TTM revenue has declined and profitability/returns remain modest, limiting resilience if demand weakens.
Income Statement
63
Positive
Profitability has stabilized after a major 2022 loss: net margin is positive again in 2023–2024 and remains modestly positive in TTM (Trailing-Twelve-Months). Gross margin is fairly steady around the high-30% to ~40% range, supporting consistent underlying economics. However, growth has cooled—TTM (Trailing-Twelve-Months) revenue is down versus the prior year—and overall earnings power remains mid-single-digit margins, leaving limited cushion if demand weakens.
Balance Sheet
70
Positive
Leverage looks manageable with debt at roughly 0.30x equity in TTM (Trailing-Twelve-Months), improving versus 2023, and equity remains sizable relative to assets. Returns on equity have recovered to ~4% in 2024/TTM (Trailing-Twelve-Months) after being deeply negative in 2022, signaling a return to more normal operations. The key drawback is that returns are still modest, implying the balance sheet is solid but not being converted into high shareholder returns.
Cash Flow
66
Positive
Cash generation is consistently positive: operating cash flow and free cash flow are solid in 2023–2024 and remain healthy in TTM (Trailing-Twelve-Months), with free cash flow also showing strong growth in the latest period. Cash conversion is decent (free cash flow is roughly three-quarters of net income in 2024/TTM (Trailing-Twelve-Months)), which supports financial flexibility. A watch item is that operating cash flow remains a relatively small share of revenue (mid-teens), so cash generation could be sensitive if margins compress or working capital swings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue159.76M164.26M158.65M137.64M110.58M104.54M
Gross Profit61.19M65.82M61.19M48.80M48.21M44.92M
EBITDA15.58M17.19M21.34M-59.70M7.32M10.58M
Net Income5.34M5.65M3.60M-75.17M-3.85M13.90M
Balance Sheet
Total Assets213.87M225.89M233.41M215.43M281.19M294.07M
Cash, Cash Equivalents and Short-Term Investments24.24M20.75M14.04M9.99M8.20M8.63M
Total Debt39.71M43.10M49.76M50.38M45.55M57.70M
Total Liabilities80.19M88.83M98.75M84.96M75.83M85.61M
Stockholders Equity133.68M137.07M134.66M130.47M205.36M208.46M
Cash Flow
Free Cash Flow15.11M16.22M8.15M280.00K14.07M1.14M
Operating Cash Flow19.98M21.53M13.05M4.89M19.07M11.31M
Investing Cash Flow-4.87M-5.31M-7.45M-5.39M-7.36M-23.98M
Financing Cash Flow-10.82M-9.66M-2.56M1.48M-12.89M-10.78M

Cellularline SpA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.76
Price Trends
50DMA
2.58
Positive
100DMA
2.68
Negative
200DMA
2.77
Negative
Market Momentum
MACD
<0.01
Negative
RSI
56.73
Neutral
STOCH
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:CELL, the sentiment is Positive. The current price of 2.76 is above the 20-day moving average (MA) of 2.59, above the 50-day MA of 2.58, and below the 200-day MA of 2.77, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.73 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:CELL.

Cellularline SpA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
€306.54M15.005.62%6.66%5.75%8.26%
66
Neutral
€112.49M4.4717.82%4.15%-5.58%165.78%
65
Neutral
€59.11M10.543.58%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
47
Neutral
€53.17M-0.86-51.98%-23.11%-284.12%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:CELL
Cellularline SpA
2.63
0.18
7.35%
IT:PRT
Esprinet Spa
6.27
2.05
48.51%
IT:ETH
Eurotech S.p.A.
0.89
0.05
5.56%
IT:INDB
Indel B S.p.A.
19.70
-1.46
-6.89%
IT:CYB
Cyberoo S.p.A.
1.39
-0.25
-14.98%
IT:SPN
Spindox S.P.A
12.95
2.97
29.76%

Cellularline SpA Corporate Events

Cellularline Reports Resilient Financial Performance Amid Challenging Market Conditions
Nov 5, 2025

Cellularline S.p.A. reported a slight decrease in consolidated revenues to €113.2 million for the first nine months of 2025, compared to the same period in 2024, due to challenging international market conditions. Despite this, the company managed to reduce its net financial debt significantly and maintained a solid financial position. The domestic market showed resilience with growth in the Red Line product category, while international markets faced a slowdown. The company continues to focus on cost optimization and strategic partnerships to enhance its market position and generate sustainable value for stakeholders.

The most recent analyst rating on (IT:CELL) stock is a Hold with a EUR3.00 price target. To see the full list of analyst forecasts on Cellularline SpA stock, see the IT:CELL Stock Forecast page.

Cellularline Announces CFO Transition
Oct 16, 2025

Cellularline S.p.A. announced that Mauro Borgogno, the Group Chief Financial Officer and Executive responsible for corporate accounting documents, will step down from his roles effective December 1, 2025, due to personal reasons and a reduction in professional commitments. Borgogno will continue to serve as an administrator of the company, ensuring operational continuity until his departure. The company will announce a successor in due course, highlighting the importance of a smooth transition for maintaining its market position.

The most recent analyst rating on (IT:CELL) stock is a Hold with a EUR3.00 price target. To see the full list of analyst forecasts on Cellularline SpA stock, see the IT:CELL Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 14, 2026